These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1048 related items for PubMed ID: 15862952

  • 1. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A, Bouclier C, Marsaud V, Maillard S, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 3. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2007 May 01; 104(3-5):110-22. PubMed ID: 17478088
    [Abstract] [Full Text] [Related]

  • 4. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.
    Int J Oncol; 2005 Aug 01; 27(2):327-35. PubMed ID: 16010412
    [Abstract] [Full Text] [Related]

  • 5. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
    Cestac P, Sarrabayrouse G, Médale-Giamarchi C, Rochaix P, Balaguer P, Favre G, Faye JC, Doisneau-Sixou S.
    Breast Cancer Res; 2005 Aug 01; 7(1):R60-70. PubMed ID: 15642170
    [Abstract] [Full Text] [Related]

  • 6. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J, Slivova V, Sliva D.
    Int J Oncol; 2006 Sep 01; 29(3):695-703. PubMed ID: 16865287
    [Abstract] [Full Text] [Related]

  • 7. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y, Chen S.
    Cancer Res; 2003 Jul 01; 63(13):3546-55. PubMed ID: 12839940
    [Abstract] [Full Text] [Related]

  • 8. Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells.
    Fortunati N, Bertino S, Costantino L, De Bortoli M, Compagnone A, Bandino A, Catalano MG, Boccuzzi G.
    Mol Cell Endocrinol; 2010 Jan 15; 314(1):17-22. PubMed ID: 19772891
    [Abstract] [Full Text] [Related]

  • 9. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.
    Lee SO, Nadiminty N, Wu XX, Lou W, Dong Y, Ip C, Onate SA, Gao AC.
    Cancer Res; 2005 Apr 15; 65(8):3487-92. PubMed ID: 15833885
    [Abstract] [Full Text] [Related]

  • 10. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K.
    Cancer Res; 2007 Apr 15; 67(8):3955-62. PubMed ID: 17440111
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, Balaguer P.
    Biochem Pharmacol; 2006 May 14; 71(10):1459-69. PubMed ID: 16554039
    [Abstract] [Full Text] [Related]

  • 12. Influence of oestradiol and tamoxifen on oestrogen receptors-alpha and -beta protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells.
    Horner-Glister E, Maleki-Dizaji M, Guerin CJ, Johnson SM, Styles J, White IN.
    J Mol Endocrinol; 2005 Dec 14; 35(3):421-32. PubMed ID: 16326830
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line.
    Gottfried-Blackmore A, Croft G, McEwen BS, Bulloch K.
    Brain Res; 2007 Dec 14; 1186():41-7. PubMed ID: 18021758
    [Abstract] [Full Text] [Related]

  • 14. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
    Sauvé K, Lepage J, Sanchez M, Heveker N, Tremblay A.
    Cancer Res; 2009 Jul 15; 69(14):5793-800. PubMed ID: 19584281
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]

  • 16. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
    Rousseau C, Nichol JN, Pettersson F, Couture MC, Miller WH.
    Mol Cancer Res; 2004 Sep 17; 2(9):523-31. PubMed ID: 15383631
    [Abstract] [Full Text] [Related]

  • 17. Dual effects of daidzein on chicken hepatic vitellogenin II expression and estrogen receptor-mediated transactivation in vitro.
    Ni YD, Hong WJ, Zhou YC, Grossmann R, Zhao RQ.
    Steroids; 2010 Mar 17; 75(3):245-51. PubMed ID: 20043933
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH.
    Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1221-6. PubMed ID: 16169518
    [Abstract] [Full Text] [Related]

  • 19. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O, Lattrich C, Springwald A, Ortmann O.
    Breast Cancer Res Treat; 2010 Apr 04; 120(3):557-65. PubMed ID: 19434490
    [Abstract] [Full Text] [Related]

  • 20. Transcription factor decoy against promoter C of estrogen receptor alpha gene induces a functional ER alpha protein in breast cancer cells.
    Lambertini E, Penolazzi L, Magaldi S, Giordano S, Senno LD, Piva R.
    Breast Cancer Res Treat; 2005 Jul 04; 92(2):125-32. PubMed ID: 15986121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.